Literature DB >> 22674450

[A young woman with fulminant pulmonary embolism].

T Spinner1, M Segerer, A Holub, C Spes, H Mudra.   

Abstract

We describe the case of a 24-year-old woman who was admitted to the emergency department with dyspnea and sinus tachycardia. The suspected diagnosis of pulmonary embolism was confirmed by computed tomography (CT) scan. The patient lost consciousness soon afterwards and was found to be pulseless. Cardiopulmonary resuscitation was performed and high dosis thrombolysis was given. The patient survived without sequelae and was discharged on oral anticoagulation from the hospital 8 days after the initial admission. In our opinion unknown factor-V Leiden in combination with a local form of hormonal contraception (NuvaRing®) was responsible for the deep venous thrombosis of the left leg and the pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674450     DOI: 10.1007/s00108-012-3082-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

Review 1.  [Acute pulmonary heart disease caused by pulmonary artery embolism].

Authors:  M P Heintzen; B E Strauer
Journal:  Internist (Berl)       Date:  1999-07       Impact factor: 0.743

2.  Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

Authors:  D A Sandler; J F Martin
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

Review 3.  The combined contraceptive vaginal device (NuvaRing): a comprehensive review.

Authors:  N N Sarkar
Journal:  Eur J Contracept Reprod Health Care       Date:  2005-06       Impact factor: 1.848

4.  Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.

Authors:  Stavros Konstantinides; Annette Geibel; Gerhard Heusel; Fritz Heinrich; Wolfgang Kasper
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 5.  Sudden death from pulmonary thromboembolism: chronobiological aspects.

Authors:  M Gallerani; R Manfredini; L Ricci; E Grandi; R Cappato; G Calò; P L Pareschi; C Fersini
Journal:  Eur Heart J       Date:  1992-05       Impact factor: 29.983

6.  Novel management strategy for patients with suspected pulmonary embolism.

Authors:  N Kucher; C M Luder; T Dörnhöfer; S Windecker; B Meier; O M Hess
Journal:  Eur Heart J       Date:  2003-02       Impact factor: 29.983

Review 7.  Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.

Authors:  Jasna Lenicek Krleza; Gordana Jakovljevic; Ana Bronic; Désirée Coen Herak; Aleksandra Bonevski; Jasminka Stepan-Giljevic; Goran Roic
Journal:  Pathophysiol Haemost Thromb       Date:  2010-07-20

Review 8.  [Diagnosis, therapy and secondary prophylaxis of acute pulmonary embolism. Presentation of and commentary on the new ESC 2008 guidelines].

Authors:  A Walther; A Schellhaass; B W Böttiger; S Konstantinides
Journal:  Anaesthesist       Date:  2009-10       Impact factor: 1.041

9.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

Review 10.  Factor V Leiden thrombophilia.

Authors:  Jody Lynn Kujovich
Journal:  Genet Med       Date:  2011-01       Impact factor: 8.822

View more
  2 in total

1.  Retinal vein occlusion associated with combined hormonal contraceptive vaginal ring use.

Authors:  Albert S Li; Jonathan Naysan; Ronni M Lieberman
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

2.  [Is non-oral hormonal contraception really free of risks? Comment on the case report by Spinner et al].

Authors:  C Thomssen
Journal:  Internist (Berl)       Date:  2012-08       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.